Your Voice Your Vote 2024

Live results
Last Updated: April 23, 10:42:16PM ET

Clinical Trials Update: May 8, 2009

ByABC News
May 8, 2009, 2:52 PM

May 9 -- (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:

Urinary Incontinence

If you are an adult with a frequent urge to urinate, difficulty preventing leakage or other problems with urinating, you may qualify for this study.

The research site is in Mountlake Terrace, Wash.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=195.

-----

Migraine and Cluster Headaches

If you are an adult who has a migraine headache at least once a year, you may qualify for this study.

The research site is in Winston-Salem, N.C.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=100.

-----

Lupus

If you are at least 16 and have been diagnosed with systemic lupus erythematosus (SLE) and active kidney disease (lupus nephritis), you may qualify for this study.

The research site is in Detroit, Mich.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=384.

-----

Anemia

If you have iron deficiency anemia, you may qualify for this study of an investigational treatment.

The research site is in Miami, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/anemia.aspx.

-----

Dry AMD-Age Macular Degeneration

If you have dry AMD age-related macular degeneration, you may qualify for this study of an investigational drug.

The research site is in Phoenix, Ariz.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/macular_degeneration.aspx.

-----

Keloids (Thick Scars)

This study will evaluate the safety and effectiveness of an investigational medication given after keloid removal surgery. If you qualify, consultation with a board certified plastic surgeon and subsequent surgery will be provided at no cost.

The research site is in Pasadena, Calif.